Functionalized nanoparticles enable tracking the rapid entry and release of doxorubicin in human pancreatic cancer cells


Journal article


Maheshika P Arachchige, Suvra S Laha, Akshata R Naik, Kenneth T Lewis, Ratna Naik, Bhanu P Jena
Micron, Elsevier, 2017, pp. 25--31

Cite

Cite

APA
Arachchige, M. P., Laha, S. S., Naik, A. R., Lewis, K. T., Naik, R., & Jena, B. P. (2017). Functionalized nanoparticles enable tracking the rapid entry and release of doxorubicin in human pancreatic cancer cells. Micron, 92, 25–31.

Chicago/Turabian
Arachchige, Maheshika P, Suvra S Laha, Akshata R Naik, Kenneth T Lewis, Ratna Naik, and Bhanu P Jena. “Functionalized Nanoparticles Enable Tracking the Rapid Entry and Release of Doxorubicin in Human Pancreatic Cancer Cells.” Micron 92 (2017): 25–31.

MLA
Arachchige, Maheshika P., et al. “Functionalized Nanoparticles Enable Tracking the Rapid Entry and Release of Doxorubicin in Human Pancreatic Cancer Cells.” Micron, vol. 92, Elsevier, 2017, pp. 25–31.